Investments
5Portfolio Exits
7Partners & Customers
10
Want to inform investors similar to LANXESS about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing LANXESS
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find LANXESS in 1 Expert Collection, including Synthetic Biology.
Synthetic Biology
382 items
Latest LANXESS News
Sep 22, 2023
LANXESS AG is a Germany-based company engaged in the chemicals sector. It specializes in the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. Its business activities are divided into four segments: Specialty Additives, responsible for manufacture of additives for the rubber and paint industries, among others; Advanced Intermediates, focused on the development of intermediates for the agricultural, plastics, chemicals, consumer goods, construction, tire and automotive industries, among others; Performance Chemicals, which offers material protection products, inorganic pigments, finishing agents for the leather industry and resins for water treatment, among others, and Engineering Materials, which produces technical plastics, glass fibers, fiber composites and elastomers on a urethane basis for application in the automotive, electronics and electrical engineering industries. It operates around 60 production sites worldwide. Sector
LANXESS Investments
5 Investments
LANXESS has made 5 investments. Their latest investment was in Arlanxeo as part of their Corporate Minority - II on April 4, 2016.
LANXESS Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
4/1/2016 | Corporate Minority - II | Arlanxeo | Yes | 2 | ||
6/24/2013 | Series B | |||||
2/22/2012 | Series C - II | |||||
5/21/2010 | Unattributed VC | |||||
5/5/2010 | Corporate Minority |
Date | 4/1/2016 | 6/24/2013 | 2/22/2012 | 5/21/2010 | 5/5/2010 |
|---|---|---|---|---|---|
Round | Corporate Minority - II | Series B | Series C - II | Unattributed VC | Corporate Minority |
Company | Arlanxeo | ||||
Amount | |||||
New? | Yes | ||||
Co-Investors | |||||
Sources | 2 |
LANXESS Portfolio Exits
7 Portfolio Exits
LANXESS has 7 portfolio exits. Their latest portfolio exit was Currenta on November 29, 2019.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
11/29/2019 | Acquired | Currenta | 1 | ||
Date | 11/29/2019 | ||||
|---|---|---|---|---|---|
Exit | Acquired | ||||
Companies | Currenta | ||||
Valuation | |||||
Acquirer | |||||
Sources | 1 |
LANXESS Acquisitions
11 Acquisitions
LANXESS acquired 11 companies. Their latest acquisition was DSM - Engineering Materials Business on January 10, 2023.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
1/10/2023 | Acquired Unit - Fin | 2 | ||||
5/31/2022 | Acquired Unit - Fin | 3 | ||||
8/23/2021 | Acquired Unit | 3 | ||||
4/1/2021 | ||||||
2/16/2021 |
Date | 1/10/2023 | 5/31/2022 | 8/23/2021 | 4/1/2021 | 2/16/2021 |
|---|---|---|---|---|---|
Investment Stage | |||||
Companies | |||||
Valuation | |||||
Total Funding | |||||
Note | Acquired Unit - Fin | Acquired Unit - Fin | Acquired Unit | ||
Sources | 2 | 3 | 3 |
LANXESS Partners & Customers
10 Partners and customers
LANXESS has 10 strategic partners and customers. LANXESS recently partnered with FRX Innovations on August 8, 2023.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
8/23/2023 | Partner | Canada | FRX and LANXESS sign memorandum of understanding to develop partnership FRX Innovations and LANXESS sign memorandum of understanding to develop partnership | 2 | |
6/30/2023 | Distributor | Hong Kong | LANXESS appoints Shanghai Perfectech to distribute Lewatit® ion exchange resins The Liquid Purification Technologies business unit of specialty chemicals company LANXESS AG has entered into a new distribution agreement with Shanghai Perfectech for the supply of its Lewatit ion exchange resins for brine softening in the Chinese chlor-alkali industry effective May 1 , 2023 . | 1 | |
5/30/2023 | Partner | Canada | 1 | ||
12/29/2022 | Partner | ||||
10/13/2022 | Vendor |
Date | 8/23/2023 | 6/30/2023 | 5/30/2023 | 12/29/2022 | 10/13/2022 |
|---|---|---|---|---|---|
Type | Partner | Distributor | Partner | Partner | Vendor |
Business Partner | |||||
Country | Canada | Hong Kong | Canada | ||
News Snippet | FRX and LANXESS sign memorandum of understanding to develop partnership FRX Innovations and LANXESS sign memorandum of understanding to develop partnership | LANXESS appoints Shanghai Perfectech to distribute Lewatit® ion exchange resins The Liquid Purification Technologies business unit of specialty chemicals company LANXESS AG has entered into a new distribution agreement with Shanghai Perfectech for the supply of its Lewatit ion exchange resins for brine softening in the Chinese chlor-alkali industry effective May 1 , 2023 . | |||
Sources | 2 | 1 | 1 |
LANXESS Team
15 Team Members
LANXESS has 15 team members, including current Chief Executive Officer, President, Ming C. Chien.
Name | Work History | Title | Status |
|---|---|---|---|
Ming C. Chien | Chief Executive Officer, President | Current | |
Name | Ming C. Chien | ||||
|---|---|---|---|---|---|
Work History | |||||
Title | Chief Executive Officer, President | ||||
Status | Current |
Compare LANXESS to Competitors
A&B Ingredients supplies a range of vegetable proteins, mold inhibitors, low-sodium sea salt, antimicrobials, shelf-life extenders, probiotics, and pure juice extracts and their derivatives. It also provides technical sales and marketing, importing, distribution, application development, and technical services to the food and fine chemical industries. It was founded in 1990 and is based in Fairfield, New Jersey.
Chinova Bioworks focuses on the beverage industry, developing a natural, safe, and effective antimicrobial cocktail mixture. The company provides a targeted or broad-spectrum antimicrobial effect, protecting beverages from spoilage and enhancing their shelf-life. Chinova Bioworks was founded in 2016 and is based in Fredericton, Canada.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
